...
首页> 外文期刊>Current Pharmaceutical Design >Molecular Mechanisms of Cardiac Voltage-Gated Potassium Channelopathies
【24h】

Molecular Mechanisms of Cardiac Voltage-Gated Potassium Channelopathies

机译:心脏电压门控钾离子通道病的分子机制

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Potassium channels form highly K+ ion-selective pores in the plasma membrane of excitable cells. Voltagegated potassium (Kv) channels open in response to membrane depolarization to allow rapid diffusion of K+ ions out of the cell, thus repolarizing the cell to restore a negative resting membrane potential. Inherited mutations in Kv channel genes produce abnormal cellular repolarization and cause diseases of excitable tissues. Small molecule interactions with Kv channels can cause similar pathologies. During the last decade of research into Kv channels and associated diseases - termed ‘channelopathies’ - we have begun to understand Kv channel function and dysfunction at the molecular level. In this review, the molecular mechanisms of Kv channelopathies are discussed, with particular emphasis on the overlap between inherited and acquired disease, and the drive towards novel channel-targeted therapies.
机译:钾通道在可兴奋细胞的质膜中形成高度K +离子选择性的孔。电压门控钾(Kv)通道响应膜去极化而打开,以允许K +离子迅速扩散出细胞,从而使细胞再极化以恢复负的静息膜电位。 Kv通道基因的遗传突变会导致异常的细胞复极化,并引起可兴奋性组织疾病。小分子与Kv通道的相互作用可能导致相似的病理。在对Kv通道和相关疾病(称为“通道病”)的最后十年研究中,我们开始在分子水平上了解Kv通道的功能和功能障碍。在这篇综述中,讨论了Kv通道病的分子机制,特别着重于遗传性和获得性疾病之间的重叠,以及对新型通道靶向疗法的驱动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号